The world’s first malaria vaccine has finally been developed and furthermore given the green light signal by the EU.
Named Mosquirix, the new vaccine for malaria will start its journey by helping babies overcome the illness in Africa. It happens to be the first vaccine on the face of the globe for an infectious disease. Even in this advanced day and age, malaria inflicts its wounds on about 200 million individuals worldwide on an annual basis.
Of these 584,000 eventually succumbed to its ravages and died before their natural life span was over two years ago. The majority were little kids who had so many wishes that they wanted to fulfill as full-fledged adults.
The EU gave a thumbs up sign to the novel malaria vaccine. It is absolutely safe in its preventive powers for the little ones on the African Continent who need it most and that too on an urgent basis.
Mosquitoes breeding in swamps and ponds are the source of the dreaded disease. Termed Mosquirix, the vaccine was created by GlaxoSmithKline. Finally, prevention is a very real possibility in case of this debilitating disease.
The vaccine creation project was also given a bit of a helping hand via extensive funding by the Bill & Melinda Gates Foundation. A final stamp of approval is being sought by the makers from WHO. By the end of 2015, the “accepted” label will be given to the vaccine by the agency.
Kids who are less than five years old form the vast majority of malaria victims. Used in conjunction with netting and pesticides, the vaccine could well spell the death knell for malaria. And the African people have been hit hardest on a worldwide level by malaria. So the developed countries ought to help them in every way in getting rid of this scourge.
"While RTS,S on its own is not the complete answer to malaria, its use alongside those interventions ... such as bed nets and insecticides would provide a very meaningful contribution to controlling the impact of malaria on children in those African communities that need it the most," Andrew Witty, GSK's chief executive, said in a statement to Reuters.
"The timing, duration, and outcomes of some of the critical steps to possible vaccine implementation in African countries are not yet known," said David Kaslow, PATH's vice president of product development.
The hopes had been pinned on the creation of a malaria vaccine since many years ago. Today that promise of medicine has been fulfilled thanks to biotechnology and the advancement of science. It is indeed a miracle of modern pharmaceutical engineering that now you can simply get vaccinated against the deadly disease and avoid an upsetting episode.
How To: Buy a Pokemon Go Plus
Since the past three decades the race was on for a vaccine. Today the dream has become a reality. The license to employ the vaccine as a prophylactic measure will soon be given to GSK. Mosquirix will be available for $5 per shot in the market and a four dosage immunity course will cost the average person about $20.